Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, October 5, 2021
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
Mon, October 4, 2021
[ Mon, Oct 04th 2021
] - WOPRAI
[ Mon, Oct 04th 2021
] - WOPRAI
[ Mon, Oct 04th 2021
] - WOPRAI
[ Mon, Oct 04th 2021
] - WOPRAI
[ Mon, Oct 04th 2021
] - WOPRAI
[ Mon, Oct 04th 2021
] - WOPRAI
[ Mon, Oct 04th 2021
] - WOPRAI
[ Mon, Oct 04th 2021
] - WOPRAI
[ Mon, Oct 04th 2021
] - WOPRAI
[ Mon, Oct 04th 2021
] - WOPRAI
[ Mon, Oct 04th 2021
] - WOPRAI
[ Mon, Oct 04th 2021
] - WOPRAI
[ Mon, Oct 04th 2021
] - WOPRAI
Esther Rajavelu Upgraded (ALNY) to Strong Buy and Increased Target to $215 on, Oct 4th, 2021
Esther Rajavelu of UBS, Upgraded "Alnylam Pharmaceuticals, Inc." (ALNY) to Strong Buy and Increased Target from $141 to $215 on, Oct 4th, 2021.
Esther has made no other calls on ALNY in the last 4 months.
There are 5 other peers that have a rating on ALNY. Out of the 5 peers that are also analyzing ALNY, 2 agree with Esther's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Gary Nachman of "BMO Capital" Maintained at Hold with Increased Target to $196 on, Friday, August 27th, 2021
- Edward Tenthoff of "Piper Sandler" Downgraded from Buy to Hold and Held Target at $181 on, Wednesday, August 4th, 2021
These are the ratings of the 3 analyists that currently disagree with Esther
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $250 on, Friday, August 13th, 2021
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $216 on, Wednesday, August 4th, 2021
- David Lebovitz of "Morgan Stanley" Maintained at Buy with Increased Target to $234 on, Wednesday, August 4th, 2021
